Brussels, Belgium, March 1, 2024

Merodis, an independent corporate finance advisory firm, is pleased to announce it has successfully advised the shareholders of MedEnvision in their search for an ambitious partner to accelerate the roll-out of its global growth strategy. MedEnvision sells its products, such as the patented Gripper® and EsySuit® in 26 countries and is enjoying a torrid momentum in the US market. After garnering significant interest from both local and international investment firms, the team of MedEnvision found with Smile Invest the perfect fit regarding strategy, culture, and future ambitions.
Co-founders Prof. Dr. Kristoff Corten and Wouter Foulon, as well as CEO Dries Goyens and its management team remain firmly invested in the Company.

MedEnvision ( is a rapidly growing Belgian MedTech company in the field of orthopaedics. Its mission is to globally support surgeons, their teams, and hospitals with efficiency optimization, meaningful staff reallocation, improved staff ergonomics and infection control in the operating theatre. MedEnvision, which was founded in 2012, grew to become a highly respected partner in the orthopaedic field.
Since its commercial launch in 2015, the Company enjoyed an impressive annual sales growth and enjoys a very healthy profitability.
MedEnvision plans to, amongst other, expand its product offering, broaden the applications of its product portfolio, and increase its geographic reach.

Smile Invest ( (Smart Money for Innovation Leaders) is a European evergreen investment firm with over €500m of assets under management, financed by 40 entrepreneurial families and with a long-term focus on innovative growth companies. Smile Invest focuses on companies active in three investment themes: digitalization, healthcare and sustainability.
Since its inception in 2017 Smile Invest has built a portfolio of 15 companies. From its offices in Leuven and The Hague, the team supports ambitious entrepreneurs and management teams in realizing their growth plans.

For more information, please contact:

Dirk Marckx, +32 495 38 17 81
Victor Boes, +32 474 52 25 67